Cargando…

Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents

IMPORTANCE: Gonadotropin-releasing hormone analogue (GnRHa) use during puberty improves mental health among transgender and gender-diverse (TGD) adolescents. In previous studies, most (96.5%-98.1%) TGD adolescents who started GnRHa subsequently started gender-affirming hormones (GAH), raising concer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nos, Andrea L., Klein, David A., Adirim, Terry A., Schvey, Natasha A., Hisle-Gorman, Elizabeth, Susi, Apryl, Roberts, Christina M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627413/ https://www.ncbi.nlm.nih.gov/pubmed/36318207 http://dx.doi.org/10.1001/jamanetworkopen.2022.39758

Ejemplares similares

Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones
por: Schagen, Sebastian E E, et al.
Publicado: (2020)

Effect of Concurrent Gonadotropin-Releasing Hormone Agonist Treatment on Dose and Side Effects of Gender-Affirming Hormone Therapy in Adolescent Transgender Patients
por: Jensen, Rachel K., et al.
Publicado: (2019)

Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018)

Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022)

Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment
por: Masumori, Naoya, et al.
Publicado: (2023)

Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021)

The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand
por: Ittiphisit, Sakditat, et al.
Publicado: (2022)

The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy
por: Yau, Mabel, et al.
Publicado: (2023)

An Observational Study of Hypertension and Thromboembolism Among Transgender Patients Using Gender-Affirming Hormone Therapy
por: Pyra, Maria, et al.
Publicado: (2020)

139. Impact of the COVID-19 Pandemic on Chlamydia and Gonorrhea Testing and Care in Military Connected Adolescents
por: Chokshi, Binny, et al.
Publicado: (2023)

Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults
por: Connelly, Paul J., et al.
Publicado: (2019)

Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

Forensic alcohol calculations in transgender individuals undergoing gender‐affirming hormonal treatment
por: Maskell, Peter D., et al.
Publicado: (2022)

Gender affirming hormone therapy dosing behaviors among transgender and nonbinary adults
por: Restar, Arjee, et al.
Publicado: (2022)

Successful restoration of spermatogenesis following gender-affirming hormone therapy in transgender women
por: de Nie, Iris, et al.
Publicado: (2023)

Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy
por: Sánchez-Toscano, Esteban, et al.
Publicado: (2023)

Breast cancer in a transgender woman undergoing gender-affirming exogenous hormone therapy
por: Villalba, Michael D., et al.
Publicado: (2023)

Early preclinical work with gonadotropin-releasing hormone analogues
por: Gordon, Keith
Publicado: (2023)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database
por: Yelehe, Melissa, et al.
Publicado: (2022)

An Approach to Nonsuppressed Testosterone in Transgender Women Receiving Gender-Affirming Feminizing Hormonal Therapy
por: Maheshwari, Arvind, et al.
Publicado: (2021)

Transgender adults, gender-affirming hormone therapy and blood pressure: a systematic review
por: Connelly, Paul J., et al.
Publicado: (2021)

Effects of Gender-Affirming Hormone Therapy on Progression Along the HIV Care Continuum in Transgender Women
por: Summers, Nathan A, et al.
Publicado: (2021)

An evaluation of gonadotropin-releasing hormone analogue administered to gilts and sows on subsequent reproductive performance and piglet birth weight
por: Vangroenweghe, Frédéric, et al.
Publicado: (2016)

Potential immunological effects of gender-affirming hormone therapy in transgender people – an unexplored area of research
por: White, Alice A., et al.
Publicado: (2022)

Physical and Psychological Effects of Gender-Affirming Hormonal Treatment Using Intramuscular Testosterone Enanthate in Japanese Transgender Men
por: Kirisawa, Takahiro, et al.
Publicado: (2021)

Apparent autistic traits in transgender people: a prospective study of the impact of gender-affirming hormonal treatment
por: Mazzoli, F., et al.
Publicado: (2022)

Desire for genetically related children among transgender and gender-diverse patients seeking gender-affirming hormones
por: Kyweluk, Moira A., et al.
Publicado: (2023)

Trends in Well-Child Visits and Routine Vaccination among Children of U.S. Military Members: An Evaluation of the COVID-19 Pandemic Effects
por: Sexton, Kyle, et al.
Publicado: (2022)

Factors Associated with Gender-Affirming Surgery and Age of Hormone Therapy Initiation Among Transgender Adults
por: Beckwith, Noor, et al.
Publicado: (2017)

Access to gender-affirming hormones during adolescence and mental health outcomes among transgender adults
por: Turban, Jack L., et al.
Publicado: (2022)

Gender affirming hormonal treatment in Danish transgender persons: A nationwide register‐based study
por: Glintborg, Dorte, et al.
Publicado: (2022)

Characterising body composition and bone health in transgender individuals receiving gender‐affirming hormone therapy
por: Ford, Ky, et al.
Publicado: (2022)

ODP414 Incidence of Suicidal Events in Transgender Patients with Initiation of Gender Affirming Hormone Therapy
por: Elliott, Karma-Jaya, et al.
Publicado: (2022)

A Review of Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Adults in South Korea
por: OH, Jeong-Won, et al.
Publicado: (2022)

SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023)

SAT645 Cardiac Autonomic Modulation In Transgender Men Under Gender-affirming Hormone Therapy
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2023)

Physical and Sociodemographic Features Associated With Quality of Life Among Transgender Women and Men Using Gender-Affirming Hormone Therapy
por: Silva, Eliane D., et al.
Publicado: (2021)

Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria
por: Brik, Tessa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g0rb1gonro4n9oak1cfhdc9j3t